Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characteristics and spatial distribution of adult human corneal cell subtypes. | Sci Rep | 2021 | 34381080 | PubTator, text mining | PubMed |
Comparison of tyrosinase antibody, tyrosinase-related protein-1 and -2 antibodies, melanin-concentrating hormone receptor antibody levels with autologous serum skin test and autologous plasma skin test results in patients with vitiligo. | Postepy Dermatol Alergol | 2021 | 34377130 | PubTator, text mining | PubMed |
| Evaluation of Anti-Melanogenesis Activity of Enriched Pueraria lobata Stem Extracts and Characterization of Its Phytochemical Components Using HPLC-PDA-ESI-MS/MS. | Int J Mol Sci | 2021 | 34360871 | PubTator, text mining | PubMed |
| Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication. | Int J Mol Sci | 2021 | 34360837 | PubTator, text mining | PubMed |
| Inhibitory Effect of Avenanthramides (Avn) on Tyrosinase Activity and Melanogenesis in α-MSH-Activated SK-MEL-2 Cells: In Vitro and In Silico Analysis. | Int J Mol Sci | 2021 | 34360580 | PubTator, text mining | PubMed |
| Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma. | Biomolecules | 2021 | 34356645 | PubTator, text mining | PubMed |
| Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties. | Antioxidants (Basel) | 2021 | 34356362 | PubTator, text mining | PubMed |
| Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention. | Genes (Basel) | 2021 | 34356109 | PubTator, text mining | PubMed |
| Effects of Cocoa Genotypes on Coat Color, Platelets and Coagulation Parameters in French Bulldogs. | Genes (Basel) | 2021 | 34356108 | PubTator, text mining | PubMed |
| The possible benefits of vitamin D in COVID-19. | Nutrition | 2021 | 34352586 | PubTator, text mining | PubMed |
| Affinity Proteomics and Deglycoproteomics Uncover Novel EDEM2 Endogenous Substrates and an Integrative ERAD Network. | Mol Cell Proteomics | 2021 | 34332121 | PubTator, text mining | PubMed |
| Identification of novel MITF mutations in Chinese families with Waardenburg syndrome type II. | Mol Genet Genomic Med | 2021 | 34323021 | PubTator, text mining | PubMed |
| Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue. | Mol Cancer Res | 2021 | 34312290 | PubTator, text mining | PubMed |
| Oxyresveratrol: Sources, Productions, Biological Activities, Pharmacokinetics, and Delivery Systems. | Molecules | 2021 | 34299485 | PubTator, text mining | PubMed |
| Synergistic Effect of 300 μm Needle-Depth Fractional Microneedling Radiofrequency on the Treatment of Senescence-Induced Aging Hyperpigmentation of the Skin. | Int J Mol Sci | 2021 | 34299100 | PubTator, text mining | PubMed |
| Antimelanogenesis Effects of Theasinensin A. | Int J Mol Sci | 2021 | 34299073 | PubTator, text mining | PubMed |
| Current Advances of Nanocarrier Technology-Based Active Cosmetic Ingredients for Beauty Applications. | Clin Cosmet Investig Dermatol | 2021 | 34285534 | PubTator, text mining | PubMed |
| Current status of intralesional agents in treatment of malignant melanoma. | Ann Transl Med | 2021 | 34277838 | PubTator, text mining | PubMed |
| Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis. | Dermatol Ther (Heidelb) | 2021 | 34269967 | PubTator, text mining | PubMed |
| Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC). | BMC Cancer | 2021 | 34266404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=45